Beyond early events, select studies linked persistently elevated IL-6 to increased major adverse cardiovascular events (MACE), myocardial infarction, restenosis, and mortality over longer-term follow-up, suggesting that it persists as a risk factor beyond successful revascularization [17,19]. The gene discussed is IL6; the disease is myocardial infarction.